The intratumoral cholesterol levels were significantly correlated to Ki-67, the most widely used clinical marker of tumor proliferation, indicating that intratumoral cholesterol levels might be positively associated with worse prognosis of breast cancer patients. Here, MKI67 is linked to breast carcinoma.